In the movie, “A Beautiful Mind,” John Nash discusses the merits of he and his friends all vying for the attentions of a very beautiful woman. (click photo to view video scene)
It is at this moment that he has his epiphanal revelation on “Governing Dynamics”…
Jonh Nash: “If we all go for the blonde, we block each other. Not a single one of us is gonna get her. So then we go for her friends, but they will all give us the cold shoulder, because nobody likes to be second choice. Well, what if no one goes for the blonde? We don’t get in each other’s way, and we don’t insult the other girls. That’s the only way we win. That’s the only way we all get laid. Adam Smith said the best result comes from everyone in the group doing what’s best for himself, right? That’s what he said…Incomplete. Incomplete, okay? Because the best result will come from everyone in the group doing what’s best for himself and the group.”
Likewise, we find ourselves in this same situation in the stem cell industry. Stem cell treatment and banking is a relatively new industry and everybody is vying for position on licenses , patents and market share. This naturally results in law suits, attacks and industrial infighting.
Too bad life can’t imitate art. If the stem cell industry could condense it’s efforts towards a common goal a la Robert Nash’s theories on Governing Dynamics, just think of how many more patients we could help.
Oh well. Maybe it will never happen, but…“You see things; and you say, ‘Why?’ But I dream things that never were; and I say, ‘Why not?‘” – George Bernard Shaw
Cord Blood America: Court Grants Motion to Dismiss at Lawsuit Aimed at Blocking Acquisition
LAS VEGAS, April 5, 2011 /PRNewswire/ — Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, is pleased to announce that the Pinellas County Circuit Court granted a motion to dismiss the lawsuit filed by Cryo-Cell International against Cord Blood America, which CBAI management believed was an attempt to inhibit the pending deal between Cryo-Cell Mexico and CBAI.
“We’re delighted. When I first addressed this issue publicly on Dec 17th, I stated that this was a suit without merit, and we knew we needed to defend ourselves; even at great time and cost to the company. The lawsuit was a menace and we are pleased with the outcome. Hats off to our counsel for a job well done and to the judicial system for seeing this through to a motion to dismiss,” said Matthew Schissler, Cord Blood America’s Chairman, CEO and co-founder.